The Short squeeze is not truly mythical, but it's
Post# of 148265
(Total Views: 668)
Posted On: 07/22/2022 9:17:34 AM
The Short squeeze is not truly mythical, but it's fairly rare. It tends to happen in companies where the short interest is high. Short interest is not all that high in CYDY. 53 million of 718 million shares outstanding, or about 7 percent. Short interest below 10% indicates strong positive sentiment.
On the other hand, some of the indications for which Leron shows efficacy are worth a lot more than $10 billion. Solid-tumor cancer, NASH, Covid LH. I don't think a short squeeze is ever going to drive us much higher, but the value of Leron should do it all by itself.
On the other hand, some of the indications for which Leron shows efficacy are worth a lot more than $10 billion. Solid-tumor cancer, NASH, Covid LH. I don't think a short squeeze is ever going to drive us much higher, but the value of Leron should do it all by itself.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼